Biofarm S.A. (BVB:BIO)

Romania flag Romania · Delayed Price · Currency is RON
1.295
+0.025 (1.97%)
At close: Feb 24, 2026
Market Cap1.30B +86.4%
Revenue (ttm)318.89M +12.9%
Net Income88.21M +9.8%
EPS0.08 +9.4%
Shares Out985.37M
PE Ratio16.23
Forward PEn/a
Dividend0.03 (2.39%)
Ex-Dividend DateAug 18, 2025
Volume364,836
Average Volume135,093
Open1.285
Previous Close1.270
Day's Range1.250 - 1.315
52-Week Range0.620 - 1.315
Beta0.42
RSI83.10
Earnings DateFeb 27, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 367
Stock Exchange Bucharest Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.

Financial Statements